Eton Change In Cash vs Change To Netincome Analysis

ETON Stock  USD 12.74  0.39  3.16%   
Eton Pharmaceuticals financial indicator trend analysis is much more than just examining Eton Pharmaceuticals latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eton Pharmaceuticals is a good investment. Please check the relationship between Eton Pharmaceuticals Change In Cash and its Change To Netincome accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eton Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.

Change In Cash vs Change To Netincome

Change In Cash vs Change To Netincome Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Eton Pharmaceuticals Change In Cash account and Change To Netincome. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Eton Pharmaceuticals' Change In Cash and Change To Netincome is -0.11. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Change To Netincome in the same time period over historical financial statements of Eton Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Eton Pharmaceuticals' Change In Cash and Change To Netincome is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of Eton Pharmaceuticals are associated (or correlated) with its Change To Netincome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Netincome has no effect on the direction of Change In Cash i.e., Eton Pharmaceuticals' Change In Cash and Change To Netincome go up and down completely randomly.

Correlation Coefficient

-0.11
Relationship DirectionNegative 
Relationship StrengthInsignificant

Change In Cash

Change To Netincome

Most indicators from Eton Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eton Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eton Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.At this time, Eton Pharmaceuticals' Tax Provision is very stable compared to the past year. As of the 16th of December 2024, Enterprise Value is likely to grow to about 71.5 M, while Selling General Administrative is likely to drop about 12.9 M.
 2023 2024 (projected)
Depreciation And Amortization901K783.6K
Interest Income323.2K244.8K

Eton Pharmaceuticals fundamental ratios Correlations

0.680.730.640.890.31-0.31-0.90.930.820.81-0.320.160.820.940.440.420.940.580.930.840.950.50.980.520.94
0.680.990.040.42-0.09-0.15-0.750.570.470.73-0.64-0.230.470.650.59-0.090.630.10.660.760.540.230.61-0.190.66
0.730.990.10.47-0.08-0.16-0.790.640.520.75-0.66-0.170.520.70.61-0.040.680.190.710.790.590.240.67-0.110.7
0.640.040.10.750.3-0.71-0.290.510.810.190.180.160.810.44-0.320.170.430.320.40.160.620.310.740.870.43
0.890.420.470.750.62-0.38-0.790.80.810.610.090.30.810.840.130.540.840.60.830.620.970.720.910.750.86
0.31-0.09-0.080.30.62-0.05-0.350.310.340.130.710.650.340.42-0.150.640.430.410.40.230.550.940.340.540.43
-0.31-0.15-0.16-0.71-0.38-0.05-0.04-0.17-0.770.2-0.13-0.07-0.77-0.020.60.40.00.330.010.15-0.2-0.13-0.45-0.5-0.02
-0.9-0.75-0.79-0.29-0.79-0.35-0.04-0.9-0.56-0.910.4-0.17-0.56-0.97-0.69-0.57-0.96-0.65-0.98-0.94-0.91-0.54-0.83-0.29-0.98
0.930.570.640.510.80.31-0.17-0.90.730.76-0.370.410.730.910.550.60.910.680.920.850.880.450.910.530.92
0.820.470.520.810.810.34-0.77-0.560.730.38-0.050.311.00.63-0.080.140.620.210.610.470.740.490.890.670.63
0.810.730.750.190.610.130.2-0.910.760.38-0.55-0.120.380.910.790.480.910.530.920.940.780.320.690.060.9
-0.32-0.64-0.660.180.090.71-0.130.4-0.37-0.05-0.550.43-0.05-0.29-0.70.17-0.28-0.04-0.33-0.49-0.090.51-0.230.39-0.29
0.16-0.23-0.170.160.30.65-0.07-0.170.410.31-0.120.430.310.21-0.040.580.210.420.210.150.260.560.240.510.22
0.820.470.520.810.810.34-0.77-0.560.731.00.38-0.050.310.63-0.080.140.620.210.610.470.740.490.890.670.63
0.940.650.70.440.840.42-0.02-0.970.910.630.91-0.290.210.630.620.621.00.680.990.940.950.590.880.390.99
0.440.590.61-0.320.13-0.150.6-0.690.55-0.080.79-0.7-0.04-0.080.620.410.620.520.640.810.370.010.3-0.320.61
0.42-0.09-0.040.170.540.640.4-0.570.60.140.480.170.580.140.620.410.630.790.630.510.610.540.370.490.63
0.940.630.680.430.840.430.0-0.960.910.620.91-0.280.210.621.00.620.630.690.990.940.950.590.870.40.99
0.580.10.190.320.60.410.33-0.650.680.210.53-0.040.420.210.680.520.790.690.690.580.680.410.560.520.7
0.930.660.710.40.830.40.01-0.980.920.610.92-0.330.210.610.990.640.630.990.690.940.950.570.870.381.0
0.840.760.790.160.620.230.15-0.940.850.470.94-0.490.150.470.940.810.510.940.580.940.790.450.740.090.92
0.950.540.590.620.970.55-0.2-0.910.880.740.78-0.090.260.740.950.370.610.950.680.950.790.680.930.620.96
0.50.230.240.310.720.94-0.13-0.540.450.490.320.510.560.490.590.010.540.590.410.570.450.680.520.450.6
0.980.610.670.740.910.34-0.45-0.830.910.890.69-0.230.240.890.880.30.370.870.560.870.740.930.520.630.88
0.52-0.19-0.110.870.750.54-0.5-0.290.530.670.060.390.510.670.39-0.320.490.40.520.380.090.620.450.630.42
0.940.660.70.430.860.43-0.02-0.980.920.630.9-0.290.220.630.990.610.630.990.71.00.920.960.60.880.42
Click cells to compare fundamentals

Eton Pharmaceuticals Account Relationship Matchups

Eton Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets17.1M26.3M27.5M25.0M31.7M26.6M
Other Current Liab1.4M1.2M1.4M3.7M9.0M9.5M
Total Current Liabilities2.0M3.8M4.6M6.5M16.2M17.1M
Total Stockholder Equity10.6M15.7M17.6M13.1M15.5M12.7M
Net Tangible Assets9.8M15.1M14.0M8.3M9.6M12.2M
Property Plant And Equipment Net1.3M1.0M219K260K150K142.5K
Net Debt(7.5M)(14.2M)(7.7M)(9.8M)(16.0M)(16.8M)
Retained Earnings(64.2M)(92.2M)(94.1M)(103.1M)(104.1M)(109.3M)
Accounts Payable575K2.3M1.8M1.8M1.8M1.6M
Cash12.1M21.3M14.4M16.3M21.4M19.7M
Non Current Assets Total2.1M1.6M3.9M5.0M4.9M2.9M
Non Currrent Assets Other61K40K21K12K10.8K10.3K
Other Assets61K232K21K12K10.8K10.3K
Long Term Debt4.5M6.8M5.3M5.4M6.2M4.0M
Cash And Short Term Investments12.1M21.3M14.4M16.3M21.4M19.7M
Retained Earnings Total Equity(45.9M)(64.2M)(92.2M)(103.1M)(92.8M)(97.5M)
Common Stock Shares Outstanding17.8M21.0M25.2M25.1M25.6M21.6M
Liabilities And Stockholders Equity17.1M26.3M27.5M25.0M31.7M26.6M
Non Current Liabilities Total4.6M6.9M5.3M5.5M22K20.9K
Capital Surpluse72.2M74.7M107.8M116.2M133.6M82.0M
Inventory380K1.2M550K557K911K572K
Other Current Assets2.1M4.2M6.4M1.3M1.1M1.1M
Other Stockholder Equity74.7M107.8M111.7M116.2M119.5M97.9M
Total Liab6.5M10.7M9.8M12.0M16.3M9.2M
Net Invested Capital15.1M22.7M24.3M19.5M20.9M19.2M
Property Plant And Equipment Gross1.3M1.0M219K260K545K479.5K
Total Current Assets15.0M24.7M23.6M20.0M26.8M23.7M
Net Working Capital13.0M20.9M19.0M13.5M10.6M13.2M
Short Term Debt133K280K1.4M1.0M5.4M5.6M
Intangible Assets725K575K3.6M4.8M4.7M5.0M
Property Plant Equipment1.3M1.0M219K72K64.8K61.6K

Pair Trading with Eton Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eton Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eton Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Eton Stock

  0.85ESPR Esperion TherapeuticsPairCorr
  0.91BMY Bristol Myers SquibbPairCorr

Moving against Eton Stock

  0.91TTOO T2 BiosystmsPairCorr
  0.9AMGN Amgen IncPairCorr
  0.85PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.82JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.81MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
The ability to find closely correlated positions to Eton Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eton Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eton Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eton Pharmaceuticals to buy it.
The correlation of Eton Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eton Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eton Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eton Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Eton Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eton Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eton Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eton Pharmaceuticals Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eton Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Earnings Share
(0.26)
Revenue Per Share
1.219
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.12)
The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.